State of the Art in Pathogenesis and Targeted Therapy in Chronic Obstructive Pulmonary Disease
A special issue of Journal of Personalized Medicine (ISSN 2075-4426). This special issue belongs to the section "Clinical Medicine, Cell, and Organism Physiology".
Deadline for manuscript submissions: 30 October 2025 | Viewed by 49
Special Issue Editor
Interests: respiratory medicine; interstitial lung diseases; bronchoscopy; interventional pulmonology; chronic obstruc-tive pulmonary disease
Special Issue Information
Dear Colleagues,
Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality worldwide, posing significant challenges to healthcare systems.
This Special Issue will delve into the latest advances in understanding the pathogenesis of COPD and innovative approaches to its targeted therapy. It will cover a broad spectrum of topics, including, but not limited to, the molecular and genetic underpinnings of COPD, the role of inflammation in disease progression, novel biomarkers for diagnosis and prognosis, and the latest developments in treatment, mostly focused on targeted therapies. Furthermore, it will explore emerging trends in personalized medicine for COPD, novel drug delivery systems, and the challenges and barriers in translating research findings into clinical practice. Ultimately, this Special Issue will inspire further research and improve patient outcomes by advancing both scientific knowledge and clinical practice in COPD management.
We encourage all researchers, clinicians, and healthcare professionals with expertise in COPD to engage with this Special Issue. We welcome contributions that showcase emerging research, clinical practices, and novel perspectives in the diagnosis and management of COPD. By sharing new data and ideas, we can collectively advance this field and improve patient care.
Dr. Emanuela Tudorache
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- COPD
- effective treatments
- molecular
- genetic
- inflammation
- biomarkers for diagnosis and prognosis
- personalized medicine
- novel drug delivery systems
- patient outcomes
- clinical practice
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
